IDEXX Laboratories Inc (IDXX) stock news · P/E 39, rev $4.30B
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
This IDXX news page leads with what IDEXX Laboratories Inc filed — not a scraped headline mill.
No cached 8-K sentence for IDXX yet. We will not pad this page with generic market recap.
Latest reported IDXX revenue for 2025-12-31 was $4.30B. Net income was $1.06B. Revenue was up 10.4% from 2024-12-31 to 2025-12-31. IDXX currently screens at market cap $43.08B and trailing P/E 39.4.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IDXX stock page; for the tape open the quote page.
IDXX stock news FAQ
What are IDXX's latest revenue and net income?
Latest cached IDEXX Laboratories Inc (IDXX) revenue for Dec 31, 2025 was $4.30B. Net income was $1.06B. Statements: https://lician.com/financials/idxx
How did IDXX revenue change from the prior cached period?
Cached IDEXX Laboratories Inc (IDXX) revenue was up 10.4% from $3.90B (Dec 31, 2024) to $4.30B (Dec 31, 2025). Statements: https://lician.com/financials/idxx
What is IDXX's P/E ratio?
IDEXX Laboratories Inc (IDXX) trailing P/E is 39.4 on the latest cached fundamentals snapshot.
What is IDXX's market cap?
IDEXX Laboratories Inc (IDXX) market cap is $43.08B on the latest cached fundamentals snapshot.
What kind of company is IDXX?
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Where is IDXX stock news listed?
Cached stock news for IDEXX Laboratories Inc (IDXX) is listed at https://lician.com/news/idxx. Filings: https://lician.com/sec/idxx
Not investment advice.